These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 22915758)

  • 1. Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy.
    Hu YL; Jahangiri A; Delay M; Aghi MK
    Cancer Res; 2012 Sep; 72(17):4294-9. PubMed ID: 22915758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy as a mechanism for anti-angiogenic therapy resistance.
    Chandra A; Rick J; Yagnik G; Aghi MK
    Semin Cancer Biol; 2020 Nov; 66():75-88. PubMed ID: 31472232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to antiangiogenic therapies.
    Bartolotti M; Franceschi E; Poggi R; Tosoni A; Di Battista M; Brandes AA
    Future Oncol; 2014 Jun; 10(8):1417-25. PubMed ID: 25052752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
    Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
    Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy.
    Selvakumaran M; Amaravadi RK; Vasilevskaya IA; O'Dwyer PJ
    Clin Cancer Res; 2013 Jun; 19(11):2995-3007. PubMed ID: 23461901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis and Metabolism: Entwined for Therapy Resistance.
    Jiménez-Valerio G; Casanovas O
    Trends Cancer; 2017 Jan; 3(1):10-18. PubMed ID: 28718423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy.
    Hu YL; Jahangiri A; De Lay M; Aghi MK
    Autophagy; 2012 Jun; 8(6):979-81. PubMed ID: 22714142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible role of chemotherapy in antiangiogenic drug resistance.
    Bocci G; Loupakis F
    Med Hypotheses; 2012 May; 78(5):646-8. PubMed ID: 22365648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic therapies: going beyond their limits.
    Moserle L; Jiménez-Valerio G; Casanovas O
    Cancer Discov; 2014 Jan; 4(1):31-41. PubMed ID: 24356098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic strategies and agents in clinical trials.
    Rosen L
    Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic Resistance: Novel Angiogenesis Axes Uncovered by Antiangiogenic Therapies Research.
    Jiménez-Valerio G; Casanovas O
    Curr Drug Targets; 2016; 17(15):1728-1734. PubMed ID: 26926466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy.
    Glade Bender J; Cooney EM; Kandel JJ; Yamashiro DJ
    Drug Resist Updat; 2004; 7(4-5):289-300. PubMed ID: 15533766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy.
    Eng CH; Wang Z; Tkach D; Toral-Barza L; Ugwonali S; Liu S; Fitzgerald SL; George E; Frias E; Cochran N; De Jesus R; McAllister G; Hoffman GR; Bray K; Lemon L; Lucas J; Fantin VR; Abraham RT; Murphy LO; Nyfeler B
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):182-7. PubMed ID: 26677873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy Inhibition Improves Sunitinib Efficacy in Pancreatic Neuroendocrine Tumors via a Lysosome-dependent Mechanism.
    Wiedmer T; Blank A; Pantasis S; Normand L; Bill R; Krebs P; Tschan MP; Marinoni I; Perren A
    Mol Cancer Ther; 2017 Nov; 16(11):2502-2515. PubMed ID: 28729403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of autophagy in cancer: therapeutic implications.
    Yang ZJ; Chee CE; Huang S; Sinicrope FA
    Mol Cancer Ther; 2011 Sep; 10(9):1533-41. PubMed ID: 21878654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy: shaping the tumor microenvironment and therapeutic response.
    Maes H; Rubio N; Garg AD; Agostinis P
    Trends Mol Med; 2013 Jul; 19(7):428-46. PubMed ID: 23714574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.
    Bottsford-Miller JN; Coleman RL; Sood AK
    J Clin Oncol; 2012 Nov; 30(32):4026-34. PubMed ID: 23008289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating autophagy: a strategy for cancer therapy.
    Li JL; Han SL; Fan X
    Chin J Cancer; 2011 Oct; 30(10):655-68. PubMed ID: 21959043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment.
    Gagne P; Akalu A; Brooks PC
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.